RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,745,365 | -32.9% | 10,552,362 | +0.2% | 0.00% | -33.3% |
| Q2 2023 | $132,238,801 | -23.5% | 10,528,567 | +0.3% | 0.00% | -25.0% |
| Q1 2023 | $172,926,995 | +11.5% | 10,499,514 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $155,140,217 | -17.0% | 10,384,218 | +24.2% | 0.00% | -33.3% |
| Q3 2022 | $187,003,000 | +57.3% | 8,359,520 | +17.8% | 0.01% | +100.0% |
| Q2 2022 | $118,900,000 | -36.1% | 7,098,454 | +14.2% | 0.00% | -25.0% |
| Q1 2022 | $186,093,000 | -2.2% | 6,217,623 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $190,354,000 | +23.6% | 6,198,442 | +26.9% | 0.00% | 0.0% |
| Q3 2021 | $153,994,000 | -2.0% | 4,884,037 | +13.8% | 0.00% | 0.0% |
| Q2 2021 | $157,096,000 | +12.2% | 4,293,442 | +6.0% | 0.00% | 0.0% |
| Q1 2021 | $140,046,000 | +95.8% | 4,051,081 | +135.4% | 0.00% | +100.0% |
| Q4 2020 | $71,511,000 | +2.9% | 1,720,675 | +5.4% | 0.00% | 0.0% |
| Q3 2020 | $69,506,000 | – | 1,631,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |